BBH Market Vectors Biotech ETF
- Health & Biotech Equities
BBH - Profile
- Issuer: Van Eck
- Structure: ETF
- Expense Ratio: 0.35%
- ETF Home Page: BBH
- Inception: Dec 20, 2011
- Tax Form: 1099
- BBH Tracks This Index: Market Vectors US Listed Biotech 25 Index
- 52 Week Lo: $95.00
- 52 Week Hi: $145.52
- AUM: $823.1 M
- Shares: 5.9 M
Alternative ETFs in the Health & Biotech Equities Category
|Type||Ticker||Expense Ratio||Assets||Avg. Daily Vol||YTD Return|
|Most Liquid (Volume)|
|Top YTD Performer|
The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies. Companies included in the index derive most of their revenues from bio-technology, including companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. To be eligible for inclusion, companies must have a market capitalization exceeding $150 million, a three-month average-daily-trading volume of at least $1 million, and at least 250,000 shares traded per month.
BBH - Realtime Rating
Realtime Rating Summary
BBH is a passive ETF that seeks to replicate Market Vectors US Listed Biotech 25 Index. The Index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded biotech companies. Companies included in the index derive most of their revenues from bio-technology, including companies engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. To be eligible for inclusion, companies must have a market capitalization exceeding $150 million, a three-month average-daily-trading volume of at least $1 million, and at least 250,000 shares traded per month.
The adjacent table gives investors an individual Realtime Rating for BBH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.
BBH In-Depth Analysis
The following tables and charts contain in-depth metrics for BBH and compare it to similar peer ETFs within its ETFdb Category.
BBH - HoldingsFilings Data as of: Jul 05, 2015
Top Ten Holdings
GILD 15.74%Gilead Sciences Inc
AMGN 10.96%Amgen Inc
CELG 9.98%Celgene Corp
BIIB 7.87%Biogen Inc
ALXN 5.93%Alexion Pharmaceuticals Inc
BMRN 4.94%Biomarin Pharmaceutical Inc
REGN 4.89%Regeneron Pharmaceuticals Inc
ILMN 4.48%Illumina Inc
INCY 4.36%Incyte Corp
VRTX 4.36%Vertex Pharmaceuticals Inc
This section compares how balanced and deep BBH is relative to the peer group ETFdb Category.
BBH Asset Allocation
BBH Sector Breakdown
BBH Market Cap Breakdown
BBH Region Breakdown
BBH Market Tier Breakdown
BBH Country Breakdown
BBH - Expenses & Fees
This section compares the cost efficiency of BBH to peers in the same ETFdb Category.
Expenses Ratio Analysis
Commission Free Trading in BBH
BBH is not currently available for commission free trading on any platforms.
Category Commission Free Trading
There are 3 other ETFs in the Health & Biotech Equities ETFdb Category that are also eligible for commission free trading:
BBH - Performance
This section shows how BBH has performed relative to its peer group ETFdb Category.
BBH - Charts
The following charts can be customized to display historical performance in a number of different formats, including line charts, bar charts, and candlesticks. Time periods can be adjusted to increase or decrease the period shown, ranging from five minutes to several months.
The following chart also includes the option to compare the performance of BBH relative to other ETFs and benchmarks or to include indicators such as Bollinger Bands, relative strength, and moving averages.
BBH - Technicals
BBH Volatility Analysis
This section shows how the volatility of BBH compares to the peer group ETFdb Category.
- 20 Day MA: $139.15
- 60 Day MA: $135.94
- MACD 15 Period: -0.77
- MACD 100 Period: 5.74
- Williams % Range 10 Day: 51.19
- Williams % Range 20 Day: 41.73
- RSI 10 Day: 53
- RSI 20 Day: 54
- RSI 30 Day: 54
- Ultimate Oscillator: 48
BBH Bollinger Bands
- Lower Bollinger (10 Day): $134.26
- Upper Bollinger (10 Day): $146.24
- Lower Bollinger (20 Day): $131.82
- Upper Bollinger (20 Day): $146.43
- Lower Bollinger (30 Day): $131.68
- Upper Bollinger (30 Day): $145.29
BBH Support & Resistance
- Support Level 1: $139.14
- Support Level 2: $138.37
- Resistance Level 1: $140.85
- Resistance Level 2: $141.79
- Stochastic Oscillator %D (1 Day): 54.25
- Stochastic Oscillator %D (5 Day): 56.76
- Stochastic Oscillator %K (1 Day): 54.30
- Stochastic Oscillator %K (5 Day): 46.63
Latest BBH News
New Highs & Lows February 15th Edition
Buy On The Dip Prospects January 27th Edition
New Highs & Lows January 18th Edition
2014 Morningstar, Inc. All Rights Reserved. The information contained herein: ( 1 ) is proprietary to Morningstar and/or its content providers; ( 2 ) may not be copied or distributed; and ( 3 ) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.